| 000 | 015460000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025444.0 | ||
| 008 | 061118s2005 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.18.M.Sc.2005.Ma.S. | ||
| 100 | 0 | _aMaha Assem Hussien | |
| 245 | 1 | 0 |
_aSerum insulin like growth factor - I in diabetic patients with macrovascular complications / _cMaha Assem Hussien ; Supervised Afaf Elsawi , Tarek Saad Eldin Hishmat , Sahar Abd El ati |
| 246 | 1 | 5 | _aدراسة قياس مستوى معامل النمو الشبيه بالانسولين رقم 1 فى الدم لمرضى السكر المصحوب بمضاعفات بالاوعية الدموية |
| 260 |
_aCairo : _bMaha Assem Hussien , _c2005 |
||
| 300 |
_a114P : _bdiagrs ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine | ||
| 520 | _aIGF - 1 is an important metabolic homone thus premature and the progressive decline in serum IGF - 1 bioactivity in aging patients with type 2 diabetes | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDiabetes type 2 | |
| 653 | 4 | _aMarovascular complications | |
| 653 | 4 | _aSerum IGF - 1 | |
| 700 | 0 |
_aAfaf Elsawi , _eSupervisor |
|
| 700 | 0 |
_aSahar Abd El ati , _eSupervisor |
|
| 700 | 0 |
_aTarek Saad Eldin Hishmat , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c13349 _d13349 |
||